Skip to Content

Join the 'Beclomethasone Dipropionate' group to help and get support from people like you.

Beclomethasone Dipropionate News

Teva Announces FDA Approval of QNASL for Children with Seasonal and Perennial Allergic Rhinitis

Posted 21 Dec 2014 by

JERUSALEM--(BUSINESS WIRE)--Dec. 19, 2014-- Teva Pharmaceutical Industries Ltd., announced today that the U.S. Food and Drug Administration (FDA) approved QNASL (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis (AR) in children 4-11 years of age. QNASL 40 mcg is a lower dose formulation of QNASL Nasal Aerosol (80 mcg), a waterless ...

Ask a Question